StonvexLoading…
StonvexStonvexStonvexCore line items from TH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $274.83M | $265.91M | $365.63M | $333.70M |
Operating Income | $-34.75M | $108.78M | $240.61M | $174.37M |
Net Income | $-37.12M | $71.27M | $173.70M | $73.94M |
EPS (Diluted) | $-0.37 | $0.70 | $1.56 | $0.74 |
Total Assets | $530.21M | $725.77M | $694.35M | $771.73M |
Total Liabilities | $141.15M | $304.68M | $317.05M | $570.88M |
Cash & Equivalents | $8.35M | $190.67M | $103.93M | $181.67M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 99.80M | 98.95M | 101.66M | 100.32M |